Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Learn essential ways to get started in real estate investing, paving your path to financial independence. Begin your investment journey today.
23,306 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A coalition-backed stablecoin launches as a potential disruptor to USDC. This shift could reshape how institutions ea...
Aflac has a remarkable 43-year streak of raising its dividend, a hallmark many income investors look for. But that st...
Leveraged ETFs promise amplified daily moves, but their aggressive design can yield surprising results. This guide br...
As the S&P 500 sits near record highs, leadership is shifting toward defensive names. This article explains why consu...
A jailed crypto founder weighs in on a high-stakes regulatory bill, and senators from both parties push back. The cla...
B&G Foods is in the spotlight as its stock roars higher. This article explains the mix of quarterly results, strategi...
Investors are asking, Has Intel's stock peaked? This in-depth guide breaks down the catalysts, risks, and valuation s...
As demand for critical minerals grows, The Metals Company (TMC) sits at a pivotal price point. This guide explores wh...
Memes have evolved from jokes into a serious branding engine. In 2026, chuck norris never dies: anchors licensing dea...
Shield AI's new CEO asserts the company is at a pivotal moment, as its battlefield-tested drones and software shift f...
A major institutional move signals a shift in risk tolerance and strategy. Learn what arcus capital scales back means...